155 related articles for article (PubMed ID: 21692059)
1. Treatment adherence and outcome in women with inflammatory breast cancer: does race matter?
Andic F; Godette K; O'Regan R; Zelnak A; Liu T; Rizzo M; Gabram S; Torres M
Cancer; 2011 Dec; 117(24):5485-92. PubMed ID: 21692059
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
Dignam JJ
J Natl Cancer Inst Monogr; 2001; (30):36-43. PubMed ID: 11773290
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
[TBL] [Abstract][Full Text] [Related]
4. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
[TBL] [Abstract][Full Text] [Related]
5. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043366
[TBL] [Abstract][Full Text] [Related]
6. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.
Verma PS; Howard RS; Weiss BM
Am J Hematol; 2008 May; 83(5):355-8. PubMed ID: 18186525
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
McCollum AD; Catalano PJ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS
J Natl Cancer Inst; 2002 Aug; 94(15):1160-7. PubMed ID: 12165641
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.
Bush D; Martin LW; Leman R; Chandler M; Haywood LJ;
J Natl Med Assoc; 2006 Mar; 98(3):330-9. PubMed ID: 16573295
[TBL] [Abstract][Full Text] [Related]
9. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
Tsai CJ; Li J; Gonzalez-Angulo AM; Allen PK; Woodward WA; Ueno NT; Lucci A; Krishnamurthy S; Gong Y; Yang W; Cristofanilli M; Valero V; Buchholz TA
Am J Clin Oncol; 2015 Jun; 38(3):242-7. PubMed ID: 23648437
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.
Chew DK; Nguyen LL; Owens CD; Conte MS; Whittemore AD; Gravereaux EC; Menard MT; Belkin M
J Vasc Surg; 2005 Oct; 42(4):695-701. PubMed ID: 16242557
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and cosmesis in African-American patients treated with conservative surgery and radiation therapy.
Tuamokumo NL; Haffty BG
Cancer J; 2003; 9(4):313-20. PubMed ID: 12967142
[TBL] [Abstract][Full Text] [Related]
12. Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
Sartor O; Armstrong AJ; Ahaghotu C; McLeod DG; Cooperberg MR; Penson DF; Kantoff PW; Vogelzang NJ; Hussain A; Pieczonka CM; Shore ND; Quinn DI; Small EJ; Heath EI; Tutrone RF; Schellhammer PF; Harmon M; Chang NN; Sheikh NA; Brown B; Freedland SJ; Higano CS
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):517-526. PubMed ID: 32111923
[TBL] [Abstract][Full Text] [Related]
13. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in adherence and response to combined treatment for full and subthreshold post-traumatic stress disorder and alcohol use disorders: A secondary analysis.
Ruglass LM; Pedersen A; Cheref S; Hu MC; Hien DA
J Ethn Subst Abuse; 2016; 15(4):434-448. PubMed ID: 26422415
[TBL] [Abstract][Full Text] [Related]
15. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.
Dignam JJ; Colangelo L; Tian W; Jones J; Smith R; Wickerham DL; Wolmark N
J Natl Cancer Inst; 1999 Nov; 91(22):1933-40. PubMed ID: 10564677
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive evaluation of outcomes for inflammatory breast cancer.
Yang R; Cheung MC; Hurley J; Byrne MM; Huang Y; Zimmers TA; Koniaris LG
Breast Cancer Res Treat; 2009 Oct; 117(3):631-41. PubMed ID: 19169811
[TBL] [Abstract][Full Text] [Related]
17. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
[TBL] [Abstract][Full Text] [Related]
18. Modern outcomes of inflammatory breast cancer.
Rehman S; Reddy CA; Tendulkar RD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):619-24. PubMed ID: 22445003
[TBL] [Abstract][Full Text] [Related]
19. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
20. Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
Chu QD; Burton G; Glass J; Smith MH; Li BD
J Am Coll Surg; 2010 May; 210(5):585-92, 592-4. PubMed ID: 20421009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
